Weather is not a fixed set of numbers on a forecast. It is a moving environment in which temperature, pressure, humidity, wind, light, and even subtle atmospheric forces change continuously, often unevenly, and sometimes abruptly. What matters most for the human body is rarely the daily average; it is the size, speed, duration, and direction of change. The same weather pattern may feel mild for one person and exhausting for another, depending on age, fitness, body composition, and chronic disease. This is why meteosensitivity cannot be understood only through static measurements. A body reacts to transitions, not just states. Rapid warming, sharp cooling, falling pressure, dry air, gusty winds, unstable light, and seasonal shifts can all create physiological stress, especially in infants, older adults, and people with cardiovascular , respiratory , or kidney disease . Temperature: Level, Direction, and Speed Temperature is the most familiar weather factor, but its biological eff...

A recent stroke study found that early temperature rise in the first 24 hours is a strong predictor of poor outcome , but it did not fully explain what that rise means biologically. In our book, the same phenomenon can be understood as a sign that stroke healing has moved away from eureactive optimality and toward a more complicated, hyperreactive inflammatory course .  What the article shows The article demonstrates that a single admission temperature is not very useful, while a rise in temperature during the first day is much more informative for predicting 3-month outcome in both ischemic and hemorrhagic stroke . That is an important practical finding, because it supports repeated monitoring rather than reliance on one baseline measurement. The study also suggests that antipyretic treatment should be guided by dynamic temperature change rather than by admission temperature alone. What the book adds Our book proposes a deeper interpretation : stroke is not simply necrosis, but ...

  Abstract Despite recent criticism and emerging P2Y12 inhibitors, aspirin maintains its position as the cornerstone antiplatelet agent in atherosclerotic cardiovascular disease (ASCVD) prevention. This article argues that aspirin's advantages extend beyond conventional antiplatelet effects through three mechanisms: (1) dual pharmacodynamic action—antiplatelet + antiinflammatory targeting atherosclerosis as a metabolic-inflammatory disease, (2) established efficacy in both primary and secondary prevention per current ACC/AHA/ESC guidelines, and (3) unexpected screening role in early cancer diagnosis through aspirin-triggered bleeding unmasking silent malignancies. These mechanisms collectively support aspirin as the antiplatelet of first choice in ASCVD management. Contemporary specialists should critically reassess modern attacks on aspirin before abandoning this cornerstone therapy, as in reality aspirin can occur as the better choice in both primary and secondary prevention appl...